CARSON CITY, Nev., June 9, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) has begun initial production of a homeopathic alternative for the Avian Flu. The production run is expected to produce 200,000 capsules.
Avitech has recently acquired and purchased the essential ingredient needed in the development of this new product. CMI Manufacturers Inc. has been contracted on our behalf to commence production of the natural product in capsule form.
CMI Manufacturers Inc. is well known for successfully producing some of the most innovative nutraceutical, pharmaceutical and cosmetic formulations that are available on the worldwide market today.
The homeopathic product is based on various acid derivatives of shikimic acid as well as other active ingredients including high potency anti-oxidants. It has been developed with an advanced delivery system and is intended to offer an alternative against most virulent strains of Avian Flu.
Avitech Lifesciences Inc. is in the process of attaining a registered trade name for the product and will announce the name at a later time. The Company continues to seek out other natural products it hopes will assist in the health and well being of our customers.
More information can be obtained by visiting our website at www.avitechls.com.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on the health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day to day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc.'s primary mandate is the health and life sciences sector the company's mandate will allow it to look at all investments to increase shareholder value.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.